JenniferL(Taylor)Taylor-CousarMD

PubMed

• 15 citations
  A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
  Emily Kramer-Golinkoff, Amanda Camacho, Liza Kramer, Jennifer L Taylor-Cousar
  Pediatric Pulmonology. 2022-05-01
• 682 citations
  Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double...
  Harry G.M. Heijerman, Edward F. McKone, Damian G. Downey, Eva Van Braeckel, Steven M. Rowe
  Lancet. 2019-11-23
• 1080 citations
  Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
  Peter G. Middleton, Marcus A. Mall, Pavel Dřevínek, Larry C. Lands, Edward F. McKone
  The New England Journal of Medicine. 2019-10-31

Journal Articles

• Effect of Ivacaftor in patients with cystic fibrosis, and a G551D-CFTR mutation: expanded acces program in the United States  
  Taylor-Cousar JL, Nikknian M, Gilmartin G and Pilewski J, J Cyst Fibros, 1/11/2015
• Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis  
  Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van Dalfsen JM, Joseloff E, Ramsey BW; GOAL Investigators of th..., Am J Respir Crit Care Med, 1/15/2014
• Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)  
  McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PE..., Lancet Respir Med, 1/1/2014
• A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacafor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised...  
  Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR and Rodman D; VX09-809-102 Study Group, Lancet Respir Med, 1/1/2014
• Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection  
  Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, Young KR, Saiman L, Burns JL, Govan JR,Ramsey B, Gupta R; ..., Thorax, 1/1/2013
• Genetic modifiers of liver disease in cystic fibrosis  
  Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M J..., JAMA, 1/9/2009
• A Critical Care Perpective on Immunotherapy in Lung Transplantation  
  Taylor JL and Palmer SM, J Intensive Care Med, 1/1/2006
• Mycobacterial Abscessus Chest Wall and Pulmonary Infection in a Cystic Fibrosis Lung Transplant Recipient  
  Taylor JL and Palmer SM, J Heart Lung Transplant, 1/1/2006
• HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania  
  Ole-Nguyaine S, Crump JA, Kibiki GS, Kiang K, Taylor J, Schimana W, et al, Ann Trop Med Parasitol, 1/1/2004
• Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury  
  Taylor JL, Carraway MS, Piantadosi CA, Am J Physiol, 1/1/1998
• Induction of ferritin and heme oxygenase-1 by endotoxin in the lung  
  Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA, Am J Physiol, 1/1/1998
• Lumacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR  
  Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A,..., N Engl J Med
• Join now to see all

Abstracts/Posters

• The Pharmacokinetics of N91115, An Inhibior of S Nitrosoglutathione Reductase in Cystic Fibrosis Patients
  Solomon G, Zemanick E, Taylor-Cousar, JL, Pediatr Pulmonol Suppl, 1/1/2015
• Use of clofazimine in difficult to treat nontuberculous mycobacterial infections
  Martiniano S, Sagel, S, Zemanick, E, DeVoogd, R, Accurso, F, Nick, J, Saavedra, M, Nichols, D, Taylor-Cousar, J, Levin, A, Czaja, C, Huitt, G, Kasperbauer, S, Daley, C, Pediatr Pulmonol Suppl, 1/1/2014
• Correlation of a semi-quantitative lung magnetic resonance imaging score with baseline lung function in Cystic Fibrosis
  Taylor-Cousar JL, Jin GY, Nambu A, Bieder J, Newell JD, Chung J, St. Clair C, Jones M, Puderbach M, Nichols DP, Saavedra MT, Schroeder J and Nick JA, NACFC, 1/1/2011
• Enhanced voriconazole absorption in a cystic fibrosis patient with concomitant administration of pancreatic enzymes
  Casciano M, Barber G, Taylor-Cousar JL, 1/1/2011
• Correlation of magnetic resonance imaging score with lung function in Cystic Fibrosis
  Taylor-Cousar JL, Biederer J, Puderbach M , Jin GY, Nambu A, Newell JD, Chung J, Schroeder J, St. Clair C, Jones M, Saavedra MT, Nichols DP and Nick JA, ATS, 1/1/2011
• Endobronchial instillation of Tobi following bronchoscopy during bronchoalveolar lavage (BAL) in two cystic fibrosis (CF) patients results in measurable serum concentr...
  Amarante M and Taylor JL, Pediatric Pharmacy Conference, 1/1/2006
• Join now to see all

Lectures

• Adult Issues in Cystic Fibrosis 
  1/1/2016
• Update in Cystic Fibrosis 
  Phoenix, AZ - 1/1/2016
• CF Update: CFTR Directed Therapies 
  Keystone, CO - 1/1/2015
• Cystic Fibrosis Cases 
  Keystone, CO - 1/1/2015
• Update on Clinical Trials and Novel Therapy in CF 
  1/1/2015
• Introduction to Cystic Fibrosis 
  1/1/2015
• Ivacaftor in Advanced CF Lung Disease 
  1/1/2015
• Cystic Fibrosis and Lung Transplant: A Discussion with a Physician and a Transplant Recipient 
  1/1/2015
• Cystic Fibrosis Therapeutics: Great Strides and Future Directions 
  Durham, NC - 1/1/2015
• Cystic Fibrosis Clinical Care and Research 
  Denver, CO - 1/1/2015
• CF Airway Inflammation, Biomarkers & Therapeutic Targets 
  1/1/2015
• Genetic and phenotypic characterization of chronic airway disease in non-human primates 
  1/1/2014
• The Evaluation of the Adult with Bronchiectasis: Could This be CF 
  1/1/2014
• Diagnosis and Evaluation of Adults with CF 
  1/1/2014
• Cardiovascular Disease in Adults with CF 
  1/1/2014
• Upper and Lower Airway Disease in Human and Non-Human Primates 
  Wauchula, FL - 1/1/2014
• Oral Sildenafil Reduces Airway Inflammation in Adults With Cystic Fibrosis 
  1/1/2013
• Summary of CF Clinical and Translational Research at NJH 
  1/1/2013
• Transplant: Things a Person with CF Should Know 
  1/1/2013
• Lung Transplant and Non-Pulmonary Complications in Cystic Fibrosis 
  1/1/2013
• Oral Sildenafil Reduces Airway Inflammation in Adults with CF 
  1/1/2013
• CF Clinical Research: Challenges and Updates 
  1/1/2012
• Cystic Fibrosis Advanced Disease State Training 
  1/1/2012
• Lung MRI Imaging in CF: A New Outcome Measure for Clinical Care and Clinical Research 
  1/1/2012
• Lung MRI Imaging in CF: A New Outcome Measure for Clinical Care and Clinical Research? 
  1/1/2011
• Join now to see all

Other

• ATS Policy Brief on the Pulmonary, Critical Care and Sleep Workforce 
  Taylor-Cousar JL
  http://www.thoracic.org/advocacy/policy-position-statements/index.php
  1/1/2012
• Patient Perspective on Lung Transplant 
  Taylor-Cousar JL, Cystic Fibrosis Foundation Webcast
  http://media.newsinfusion.com/LungTransplantation/
  1/1/2011